Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

Novel optic nerve-regenerating growth factor identified as potential glaucoma therapeutic

Nov. 27, 2001

New product significantly reduces the risk of AMD

Nov. 26, 2001

Alcon identifies several related series of antiglaucoma agents

Nov. 22, 2001

Positive opinion issued for Lumigan by CPMP

Nov. 21, 2001

Launch of Xalcom/Xalacom begins in Europe

Nov. 20, 2001

Six-month results presented for CAT-152 following glaucoma and cataract surgery

Nov. 16, 2001

Oculex commences phase II trial of Posurdex for PME

Oct. 30, 2001

Bausch & Lomb acquires loteprednol etabonate line

Oct. 15, 2001

Asahi Glass describes novel antiglaucoma difluoroprostaglandins

Oct. 11, 2001

Indian research institute evaluates andrographolide derivatives

Sep. 21, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 9, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome
BioWorld Science
The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...